Product NDC: | 68084-553 |
Proprietary Name: | medroxyprogesterone acetate |
Non Proprietary Name: | medroxyprogesterone acetate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; medroxyprogesterone acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68084-553 |
Labeler Name: | American Health Packaging |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011839 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120127 |
Package NDC: | 68084-553-21 |
Package Description: | 3 BLISTER PACK in 1 CARTON (68084-553-21) > 10 TABLET in 1 BLISTER PACK (68084-553-11) |
NDC Code | 68084-553-21 |
Proprietary Name | medroxyprogesterone acetate |
Package Description | 3 BLISTER PACK in 1 CARTON (68084-553-21) > 10 TABLET in 1 BLISTER PACK (68084-553-11) |
Product NDC | 68084-553 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | medroxyprogesterone acetate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120127 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | American Health Packaging |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |